SecBot SecBot
424B5 ·Filed Nov 17, 2026

MEDS

DataMeds AI, Inc.
BEARISH
Impact 6/10
Processed17m ago SEC0001493152-26-052900
Notable filing: 424B5

Price Chart

Loading chart...

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
424B5 Filing (Primary)0001493152-26-052900
Document: 0001493152-26-052900-index-headers.html0001493152-26-052900
Document: 0001493152-26-052900-index.html0001493152-26-052900
Document: 0001493152-26-052900.txt0001493152-26-052900

Track record

15 reports on MEDS

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +35.05% at T+60 after the Aug 18, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 17, 2026today 424B5 Bearish 6/10 Viewing Entry price pending
  2. Nov 17, 2026today 8-K Bearish 7/10 Entry $0.6151 Now $0.6403 −4.10% settles Nov 25
  3. Nov 16, 20261d ago 424B5 Bearish 5/10 Entry $0.6421 Now $0.6403 +0.28% settles Nov 23
  4. Nov 16, 20261d ago 8-K Neutral 3/10 Entry $0.6421 Now $0.6403 −0.28% settles Nov 23
  5. Nov 13, 20264d ago 8-K Neutral 5/10 Entry $0.6421 Now $0.6403 −0.28% settles Nov 23
  6. Nov 10, 20266d ago SC 13G Neutral 4/10 Entry $0.9531 Now $0.6403 −32.82% settles Nov 18
  7. Nov 10, 20267d ago S-1/A Bearish 6/10 Entry $0.9531 Now $0.6403 +32.82% settles Nov 18
  8. Nov 5, 202612d ago 8-K Neutral 4/10 Entry $1.22 to $0.8702 Now $0.6403 −47.52% ▼ −28.67% −31.96% vs SPY
  9. Oct 26, 202622d ago 8-K Bearish 6/10 Entry $2.06 to $1.80 Now $0.6403 +68.92% ▲ +12.62% +10.63% vs SPY
  10. Oct 20, 202628d ago 8-K Neutral 4/10 Entry $2.75 to $2.06 Now $0.6403 −76.72% ▼ −25.09% −25.17% vs SPY
Showing 10 of 15

US Market Status

Market Closed · Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 17, 2026

Fresh MEDS Intelligence

Analysis is for subscribers only.

Subscribe for Full Access